KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Net Cash Flow (2016 - 2025)

Eli Lilly's Net Cash Flow history spans 17 years, with the latest figure at -$2.5 billion for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 850.27% year-over-year to -$2.5 billion; the TTM value through Dec 2025 reached $3.6 billion, up 386.33%, while the annual FY2025 figure was $3.6 billion, 386.33% up from the prior year.
  • Net Cash Flow reached -$2.5 billion in Q4 2025 per LLY's latest filing, down from $6.4 billion in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $6.4 billion in Q3 2025 to a low of -$2.5 billion in Q4 2025.
  • Average Net Cash Flow over 5 years is $187.0 million, with a median of $2.6 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: tumbled 16689.47% in 2023, then soared 7933.5% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $251.0 million in 2021, then crashed by 268.21% to -$422.2 million in 2022, then surged by 173.07% to $308.5 million in 2023, then increased by 6.13% to $327.4 million in 2024, then tumbled by 850.27% to -$2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Net Cash Flow are -$2.5 billion (Q4 2025), $6.4 billion (Q3 2025), and $7.1 million (Q2 2025).